These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19681114)

  • 1. Now, I am proud to be a Radialist.
    Saito S
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):418-9. PubMed ID: 19681114
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventable deaths, never events, and comparative effectiveness: it is time for US cardiologist to switch to transradial.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):416-7. PubMed ID: 19681112
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions].
    Fettser DV; Preobrazhenskiĭ DV; Batyraliev TA; Sidorenko BA; Aĭtach V
    Ter Arkh; 2009; 81(1):84-7. PubMed ID: 19253720
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal management of acute coronary syndromes.
    Hillis LD; Lange RA
    N Engl J Med; 2009 May; 360(21):2237-40. PubMed ID: 19458369
    [No Abstract]   [Full Text] [Related]  

  • 6. Should radial artery access be the "gold standard" for PCI?
    Hamon M; Nolan J
    Heart; 2008 Dec; 94(12):1530-2. PubMed ID: 18669548
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycoprotein inhibitors in patients on chronic anticoagulation: safe enough or too much risk?
    Marín F; Bonacasa B; Valdés M
    Thromb Haemost; 2010 Jan; 103(1):11-2. PubMed ID: 20062940
    [No Abstract]   [Full Text] [Related]  

  • 8. It is never too late for PCI: To relieve medically refractory myocardial ischemia.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):455-6. PubMed ID: 19235234
    [No Abstract]   [Full Text] [Related]  

  • 9. The score is in but is the decision final?
    Brinker J
    J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596
    [No Abstract]   [Full Text] [Related]  

  • 10. Transradial pharmacology: do we need access relevant dosing to maximize outcome?
    Gilchrist IC
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):69-71. PubMed ID: 20518002
    [No Abstract]   [Full Text] [Related]  

  • 11. It is standard practice, but is it really best practice or clinical biocreep?
    Gilchrist IC
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):525-6. PubMed ID: 20882656
    [No Abstract]   [Full Text] [Related]  

  • 12. Meeting the needs for antiplatelet therapy in at-risk acute coronary syndrome patients.
    Cardiovasc J Afr; 2009; 20(5):329-30, 332. PubMed ID: 19907815
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding risks with prasugrel in the TRITON trial: good news ... bad news.
    Serebruany VL
    Cardiology; 2008; 111(4):265-7. PubMed ID: 18434736
    [No Abstract]   [Full Text] [Related]  

  • 14. Prasugrel in the poststroke cohort of the TRITON Trial: the clear and present danger.
    Serebruany VL; Alberts MJ; Hanley DF
    Cerebrovasc Dis; 2008; 26(1):93-4. PubMed ID: 18547948
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
    Nikolsky E; Mehran R; Stone GW
    Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transradial intervention for minimizing bleeding complications in percutaneous coronary intervention.
    Hamon M; Coutance G
    Am J Cardiol; 2009 Sep; 104(5 Suppl):55C-9C. PubMed ID: 19695363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Femoral access bleeding complications remain an important cause of morbidity and mortality in patients undergoing interventional procedures.
    Mann JT
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):655; author reply 656. PubMed ID: 18360859
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute coronary syndromes.
    Cequier A; Gómez-Hospital JA; Gonzalez-Costello J
    N Engl J Med; 2009 Aug; 361(9):926; author reply 927. PubMed ID: 19714783
    [No Abstract]   [Full Text] [Related]  

  • 19. Intracoronary drugs during percutaneous interventions: the highway has different lanes!
    Cortese B; Biondi-Zoccai G
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):303-4. PubMed ID: 20733509
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention.
    Tiroch KA; Arora N; Matheny ME; Liu C; Lee TC; Resnic FS
    Am J Cardiol; 2008 Dec; 102(11):1473-6. PubMed ID: 19026298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.